FDA Approves New HIV Treatments

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...

Speed Test

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

AMBER Study: Phase 3 Symtuza Results

At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...

TAG’s Pipeline Report

Pipeline Report Treatment Action Group provides updates on treatments for HIV, HCV & TB by Hank Trout Treatment Action Group (TAG) has announced the release of the...

Gut Instinct

AIDS Healthcare Foundation Trains a Research Lens on Probiotics by Chael Needle "Probiotics” has become a new buzz word in the dairy aisle—at least two brands...

Janssen Announces FDA Approval of SYMTUZA

The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...

Expanded Portfolio

A new study reports on the drug-drug interaction between pitavastatin and a common PI combo by Chael Needle Last year, A&U reported on a study that...

Bio Logic

A bacterium with a live biotherapeutic grows into a microbicide candidate by Chael Needle LifeGuide The development of female-initiated HIV prevention methods—female condoms, antiretroviral treatment as prevention,...

Barriers to Treatment Use

LifeGuide Opening Doors A new survey uncovers barriers to treatment by Chael Needle There’s an old chestnut that goes something like this: People won’t make a change...

LATEST POSTS

Ron B: Cover Story

“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...